Dendreon
1700 Saturn Way
Seal Beach
CA
90740
United States
Tel: 206-256-4545
Fax: 206-256-0571
Website: http://www.dendreon.com/
322 articles about Dendreon
-
Juno Therapeutics CEO and CFO Earn Hefty Bonuses; Poaches Ex-Amgen, Dendreon Scientists
2/26/2015
-
With the Help of Two Amgen Scientists, Ex-Dendreon CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle
2/9/2015
-
Valeant Ups Bid for Dendreon Assets to $400 Million After Competing Offers Come In
2/6/2015
-
Dendreon Corporation Enters Into Amended Agreement With Valeant In Connection With Court-Supervised Sales Process
2/5/2015
-
Dendreon Corporation Gets $296 Million Cash Bid From Deal-Hungry Valeant for Provenge Assets as Bankruptcy Auction Looms
2/2/2015
-
Dendreon Corporation Provides Update On Restructuring Process
1/28/2015
-
Dendreon Corporation Announces Strong Commercial Start To 2015
1/14/2015
-
Dendreon Corporation Heads for Bankruptcy Auction Without $275 Million Minimum Bidder
1/2/2015
-
Troubled Dendreon Corporation Files For Chapter 11 Bankruptcy
11/11/2014
-
Struggling Dendreon Corporation Plunges After Warning Investors Of Debt Woes
8/14/2014
-
Flailing Dendreon Corporation Brings In Ex-Johnson & Johnson Exec For Top CEO Post
7/31/2014
-
Financially Troubled Dendreon Corporation Loses Its CEO
6/11/2014
-
Dendreon Corporation Release: Treatment With PROVENGE® (Sipuleucel-T) Induces Antigen Spread Associated With Overall Survival Benefits In Advanced Prostate Cancer
5/20/2014
-
Dendreon Corporation Announces Presentation Of PROVENGE® (sipuleucel-T) And DN24-02 Immuno-Oncology Data At The 2014 American Society of Clinical Oncology Annual Meeting
5/15/2014
-
Dendreon Corporation Announces First Quarter 2014 Results
5/8/2014
-
Dendreon Corporation To Host Conference Call On May 8 To Announce First Quarter Financial Results
4/29/2014
-
Dendreon Corporation Release: Immune Responses Enhanced And Sustained When PROVENGE® (Sipuleucel-T) Is Given After Androgen Deprivation Therapy In Biochemically-Recurrent Prostate Cancer
4/11/2014
-
Dendreon Corporation Announces Plans To Make PROVENGE® Commercially Available In Europe
3/3/2014
-
Dendreon Corporation Announces Fourth Quarter And 2013 Year End Results
3/3/2014
-
Dendreon Corporation Announces Webcast Presentation At Cowen and Company Health Care Conference
2/21/2014